You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 19, 2024

CLINICAL TRIALS PROFILE FOR SPIRIVA RESPIMAT

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for SPIRIVA RESPIMAT

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00239447 ↗	Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD	Completed	Boehringer Ingelheim	Phase 3	2002-11-01	Non-inferiority of lung function response to Tiotropium inhalation solution compared to Spiriva HandiHaler
NCT00281567 ↗	Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD)	Completed	Boehringer Ingelheim	Phase 3	2002-08-01	Comparison of lung function response between tiotropium inhalation solution and Spiriva HandiHaler.
NCT00292448 ↗	A Randomised, Double-blind, Crossover Study of Ba679BR Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD)	Completed	Boehringer Ingelheim	Phase 2	2006-02-01	The objective of this trial is to compare the efficacy and the safety of Ba 679 BR Respimat 5 ug once daily to tiotropium inhalation capsule 18 ug (Spiriva inhalation capsule) in a crossover study of 4-week treatment periods in patients with COPD.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for SPIRIVA RESPIMAT

Condition Name

Chart
Table

Condition Name for SPIRIVA RESPIMAT
Intervention	Trials
Pulmonary Disease, Chronic Obstructive	8
Healthy	4
Asthma	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for SPIRIVA RESPIMAT
Intervention	Trials
Pulmonary Disease, Chronic Obstructive	15
Lung Diseases	13
Lung Diseases, Obstructive	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for SPIRIVA RESPIMAT

Trials by Country

Map
Table

Trials by Country for SPIRIVA RESPIMAT
Location	Trials
United States	178
Italy	24
Canada	7
United Kingdom	5
Australia	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for SPIRIVA RESPIMAT
Location	Trials
South Carolina	8
Florida	7
California	7
Ohio	6
Arizona	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for SPIRIVA RESPIMAT

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for SPIRIVA RESPIMAT
Clinical Trial Phase	Trials
Phase 4	6
Phase 3	6
Phase 2/Phase 3	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for SPIRIVA RESPIMAT
Clinical Trial Phase	Trials
Completed	20
Unknown status	3
Not yet recruiting	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SPIRIVA RESPIMAT

Sponsor Name

Chart
Table

Sponsor Name for SPIRIVA RESPIMAT
Sponsor	Trials
Boehringer Ingelheim	9
3M	4
Pearl Therapeutics, Inc.	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for SPIRIVA RESPIMAT
Sponsor	Trials
Industry	23
Other	11
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.